Terms: = Ovarian cancer AND DICER1, Dicer, 23405, ENSG00000100697, KIAA0928, HERNA, Q9UPY3, K12H4_8-LIKE AND Prognosis
28 results:
1. Review on Sertoli-Leydig Cell Tumours of the Ovary.
Muscat C; Calleja-Agius J
Discov Med; 2024 Feb; 36(181):234-247. PubMed ID: 38409829
[TBL] [Abstract] [Full Text] [Related]
2. Oncological and endocrinological outcomes for children and adolescents with testicular and ovarian sex cord-stromal tumors. Results of the TGM13 National Registry.
Fuentes C; Ouldbey Y; Orbach D; Sudour-Bonnange H; Verité C; Rome A; Dumesnil C; Thebaud E; Hameury F; Dijoud F; Chabaud S; Cote MD; Fresneau B; Faure-Conter C
Pediatr Blood Cancer; 2024 Apr; 71(4):e30864. PubMed ID: 38259036
[TBL] [Abstract] [Full Text] [Related]
3. Pediatric Sertoli-Leydig Cell Tumors of the Ovary: An Integrated Study of Clinicopathological Features, Pan-cancer-Targeted Next-generation Sequencing and Chromosomal Microarray Analysis From a Single Institution.
Yang B; Chour W; Salazar CG; Zamiara P; Schmidt RJ; Raca G; Shillingford N; Zhou S; Warren M; Parham DM; Pawel B; Wang LL
Am J Surg Pathol; 2024 Feb; 48(2):194-203. PubMed ID: 37946548
[TBL] [Abstract] [Full Text] [Related]
4. Sertoli-Leydig cell tumor: a clinicopathological analysis in a comprehensive, national cohort.
Bekker P; Miland-Samuelsen AR; Smerdel MP; Schnack TH; Lauszus FF; Karstensen SH
Int J Gynecol Cancer; 2023 Dec; 33(12):1921-1927. PubMed ID: 37907261
[TBL] [Abstract] [Full Text] [Related]
5. Mixed sex cord-stromal tumor (gynandroblastoma) with malignant morphology involving both ovaries: a case report.
Maraqa B; Al-Ashhab M; Kamal N; Sughayer M; Barakat F
J Int Med Res; 2023 Jul; 51(7):3000605231187796. PubMed ID: 37493465
[TBL] [Abstract] [Full Text] [Related]
6. Outcomes for Children With Type II and Type III Pleuropulmonary Blastoma Following Chemotherapy: A Report From the International PPB/
Schultz KAP; Harris AK; Nelson AT; Watson D; Lucas JT; Miniati D; Stewart DR; Hagedorn KN; Mize W; Kamihara J; Mitchell SG; Wilson DB; Gettinger K; Rangaswami AA; Harney LA; Rodriguez Galindo C; Bisogno G; Dehner LP; Hill DA; Messinger YH
J Clin Oncol; 2023 Feb; 41(4):778-789. PubMed ID: 36137255
[TBL] [Abstract] [Full Text] [Related]
7. Embryonal Rhabdomyosarcoma of the Uterine Cervix: A Clinicopathologic Study of 94 Cases Emphasizing Issues in Differential Diagnosis Staging, and Prognostic Factors.
Devins KM; Young RH; Ghioni M; Burandt E; Bennett JA; Oliva E
Am J Surg Pathol; 2022 Nov; 46(11):1477-1489. PubMed ID: 35941719
[TBL] [Abstract] [Full Text] [Related]
8. Ascitic fluid shear stress in concert with hepatocyte growth factor drive stemness and chemoresistance of ovarian cancer cells via the c-Met-PI3K/Akt-miR-199a-3p signaling pathway.
Hassan AA; Artemenko M; Tang MKS; Shi Z; Chen LY; Lai HC; Yang Z; Shum HC; Wong AST
Cell Death Dis; 2022 Jun; 13(6):537. PubMed ID: 35676254
[TBL] [Abstract] [Full Text] [Related]
9. Consensus recommendations from the EXPeRT/PARTNER groups for the diagnosis and therapy of sex cord stromal tumors in children and adolescents.
Schneider DT; Orbach D; Ben-Ami T; Bien E; Bisogno G; Brecht IB; Cecchetto G; Ferrari A; Godzinski J; Janic D; Lopez Almaraz R; Pourtsidis A; Roganovic J; Schultz KAP; Stachowicz-Stencel T; Fresneau B
Pediatr Blood Cancer; 2021 Jun; 68 Suppl 4():e29017. PubMed ID: 33760357
[TBL] [Abstract] [Full Text] [Related]
10. Hereditary ovarian tumour syndromes: current update on genetics and imaging.
Shanbhogue KP; Prasad AS; Ucisik-Keser FE; Katabathina VS; Morani AC
Clin Radiol; 2021 Apr; 76(4):313.e15-313.e26. PubMed ID: 33353730
[TBL] [Abstract] [Full Text] [Related]
11. Sertoli-Leydig cell tumor in two siblings with dicer1 syndrome: A case report and literature review.
Zhang Y; Ren M; Hong Y; Zhong Y; Cong X; Chen C; Liu Z; Man Y; Yang L
Medicine (Baltimore); 2020 Jul; 99(27):e20806. PubMed ID: 32629665
[TBL] [Abstract] [Full Text] [Related]
12. Clinical Characteristics and Mutation Analyses of ovarian Sertoli-Leydig Cell Tumors.
Yuan Z; Huo X; Jiang D; Yu M; Cao D; Wu H; Shen K; Yang J; Zhang Y; Zhou H; Wang Y
Oncologist; 2020 Sep; 25(9):e1396-e1405. PubMed ID: 32557933
[TBL] [Abstract] [Full Text] [Related]
13. [ovarian Sertoli-Leydig cell tumors: dicer1 hotspot mutations and associated clinicopathological features].
Xiao YX; Zhu XL; Bi R; Tu XY; Cheng YF; Chang B; Yu L; Huang D; Lu YM; Shan L; Yang WT
Zhonghua Bing Li Xue Za Zhi; 2020 May; 49(5):441-447. PubMed ID: 32392927
[No Abstract] [Full Text] [Related]
14. Detection of the dicer1 hotspot mutation alongside immunohistochemical analysis may provide a better diagnostic measure for ovarian Sertoli-Leydig cell tumors.
Zhang X; Shen D; Wang Y
Pathol Res Pract; 2018 Sep; 214(9):1370-1375. PubMed ID: 30072170
[TBL] [Abstract] [Full Text] [Related]
15. miR-98-5p contributes to cisplatin resistance in epithelial ovarian cancer by suppressing miR-152 biogenesis via targeting dicer1.
Wang Y; Bao W; Liu Y; Wang S; Xu S; Li X; Li Y; Wu S
Cell Death Dis; 2018 May; 9(5):447. PubMed ID: 29670086
[TBL] [Abstract] [Full Text] [Related]
16. nc886 is induced by TGF-β and suppresses the microRNA pathway in ovarian cancer.
Ahn JH; Lee HS; Lee JS; Lee YS; Park JL; Kim SY; Hwang JA; Kunkeaw N; Jung SY; Kim TJ; Lee KS; Jeon SH; Lee I; Johnson BH; Choi JH; Lee YS
Nat Commun; 2018 Mar; 9(1):1166. PubMed ID: 29563500
[TBL] [Abstract] [Full Text] [Related]
17. Alu RNA accumulation induces epithelial-to-mesenchymal transition by modulating miR-566 and is associated with cancer progression.
Di Ruocco F; Basso V; Rivoire M; Mehlen P; Ambati J; De Falco S; Tarallo V
Oncogene; 2018 Feb; 37(5):627-637. PubMed ID: 28991230
[TBL] [Abstract] [Full Text] [Related]
18. The role of MicroRNA molecules and MicroRNA-regulating machinery in the pathogenesis and progression of epithelial ovarian cancer.
Wang X; Ivan M; Hawkins SM
Gynecol Oncol; 2017 Nov; 147(2):481-487. PubMed ID: 28866430
[TBL] [Abstract] [Full Text] [Related]
19. The prevalence of dicer1 pathogenic variation in population databases.
Kim J; Field A; Schultz KAP; Hill DA; Stewart DR
Int J Cancer; 2017 Nov; 141(10):2030-2036. PubMed ID: 28748527
[TBL] [Abstract] [Full Text] [Related]
20. β-catenin downregulates dicer to promote ovarian cancer metastasis.
To SKY; Mak ASC; Eva Fung YM; Che CM; Li SS; Deng W; Ru B; Zhang J; Wong AST
Oncogene; 2017 Oct; 36(43):5927-5938. PubMed ID: 28650464
[TBL] [Abstract] [Full Text] [Related]
[Next]
